Skip to main content
. 2016 Nov 19;55(2):717–725. doi: 10.3233/JAD-160393

Table 4.

Overview of vitamin and supplement intake during the last month among healthy controls and Alzheimer’s disease patients with MCI and dementia

Patients
All Controls MCIa ADb
(n = 136) (n = 63) (n = 25) (n = 48)
n (%) n (%) n (%) n (%)
Any vitamins in the last month, n (%) 83 (61.0) 39 (61.9) 20 (80.0) 24 (50.0)
Vitamins on the day of blood sampling, n (%) 13 (9.6) 4 (6.3) 5 (20.0) 4 (8.3)
Multivitamins, n (%) 33 (24.3) 19 (30.2) 7 (28.0) 7 (14.6)
Vitamin A, n (%) 0 0 0 0
Vitamin B (1 and 6), n (%) 13 (9.6) 7 (11.1) 2 (8.0) 4 (8.3)
Vitamin B12, n (%) 3 (2.2) 1 (1.6) 0 2 (4.2)
Folic Acid, n (%) 2 (1.5) 1 (1.6) 0 1 (2.1)
TrioBe, n (%) 9 (6.6) 2 (3.2) 4 (16.0) 3 (6.3)
Vitamin C, n (%) 19 (14.0) 9 (14.3) 1 (4.0) 9 (18.8)
Vitamin D, n (%) 12 (8.8) 3 (4.8) 3 (12.0) 6 (12.5)
Vitamin E, n (%) 1 (0.7) 0 0 1 (2.1)
Calcium, n (%) 10 (7.4) 4 (6.3) 4 (16.0) 2 (4.2)
Omega-3 or Fish oil, n (%) 61 (44.9) 30 (47.6) 14 (56.0) 17 (35.4)
Other supplements, n (%) 27 (19.9) 10 (15.9) 7 (28.0) 10 (20.8)

aMCI according to the Winblad criteria; bAlzheimer’s dementia according to the NINCDS-ADRDA criteria.